Literature DB >> 25114408

Rare case of acquired haemophilia and lupus anticoagulant.

Devika Gupta1, Tathagat Chatterjee1, Ajay Sharma1, Prosenjit Ganguli1, Satyaranjan Das1, Sanjeevan Sharma1.   

Abstract

Acquired haemophilia or factor VIII (FVIII) deficiency, caused by FVIII inhibitor antibodies, is a very rare condition that commonly results in severe haemorrhagic complications. We report a case of acquired haemophilia presenting with multiple bluish patches affecting face, neck, upper & lower limbs, history of gum bleeding and left knee haemarthrosis. The patient was found to have acquired FVIII inhibitor and lupus anticoagulant (LAC). The simultaneous presence of LAC and FVIII inhibitor is exceedingly rare. The differentiation between these two conditions is crucial, because both result in a prolongation of the activated partial thromboplastin time test, which does not correct when mixed with the plasma of a normal control; however, the clinical manifestations range from thrombosis in the presence of LAC to massive haemorrhage with FVIII inhibitors.

Entities:  

Keywords:  Acquired haemophilia; Factor VIII inhibitor; Lupus anticoagulant

Year:  2012        PMID: 25114408      PMCID: PMC4115089          DOI: 10.1007/s12288-012-0204-5

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  14 in total

1.  Successful management of life-threatening hemorrhage in a patient with synchronous lupus anticoagulant and factor VIII inhibitor.

Authors:  Hans A Brings; John K Waas; Keith R McCrae; Henry R Baele; Jerry Goldstone
Journal:  J Vasc Surg       Date:  2002-10       Impact factor: 4.268

Review 2.  Inhibitors to clotting factors.

Authors:  S Sallah
Journal:  Ann Hematol       Date:  1997 Jul-Aug       Impact factor: 3.673

3.  Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.

Authors:  I Jennings; S Kitchen; T A Woods; F E Preston; M Greaves
Journal:  Thromb Haemost       Date:  1997-05       Impact factor: 5.249

4.  Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients.

Authors:  S Sallah; J Y Wan
Journal:  Cancer       Date:  2001-03-15       Impact factor: 6.860

5.  Acquired haemophilia - a study of ten cases.

Authors:  R Saxena; D K Mishra; R Kashyap; V P Choudhry; M Mahapatra; M Bhargava
Journal:  Haemophilia       Date:  2000-03       Impact factor: 4.287

Review 6.  Factor VIII inhibitors. Laboratory diagnosis of inhibitors.

Authors:  M A Sahud
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

Review 7.  The use of recombinant factor VIIa in the treatment of bleeding disorders.

Authors:  Harold R Roberts; Dougald M Monroe; Gilbert C White
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

8.  ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay.

Authors:  M A Sahud; K P Pratt; O Zhukov; K Qu; A R Thompson
Journal:  Haemophilia       Date:  2007-05       Impact factor: 4.287

9.  A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.

Authors:  D Green; K Lechner
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

Review 10.  The management of hemophilia in elderly patients.

Authors:  Massimo Franchini; Annarita Tagliaferri; Pier Mannuccio Mannucci
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more
  5 in total

1.  Co-existent Acquired Haemophilia and Lupus Anticoagulant. A Thorny Issue.

Authors:  Paul R J Ames; Daniel Montero; Jeremy Archer
Journal:  Indian J Hematol Blood Transfus       Date:  2015-07-22       Impact factor: 0.900

2.  Acquired Hemophilia A: Experience of a Tertiary Care Institute from North India.

Authors:  Narender Kumar; Sweta Rajpal; Jasmina Ahluwalia; Sunil Bose; Varun Uppal; Neelam Varma; Pankaj Malhotra; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-18       Impact factor: 0.900

3.  Coexistence of Acquired Hemophilia and Antiphospholipid Serology in Monoclonal Gammopathy Patient.

Authors:  Nabil Belfeki; Sarra Hamrouni; Alessio Strazzulla; Sylvain Diamantis
Journal:  Int Med Case Rep J       Date:  2021-04-28

4.  Acquired hemophilia A in the setting of dual anticoagulation therapy and lupus anticoagulant: a case report.

Authors:  Victor Chen; Lauren C Roby; Stephanie Wentzel; Mingjia Li; Nicholas Jones
Journal:  J Med Case Rep       Date:  2022-05-03

5.  Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient.

Authors:  Jeremy W Jacobs; Savanah D Gisriel; Krishna Iyer; Henry M Rinder
Journal:  J Thromb Thrombolysis       Date:  2021-10-25       Impact factor: 2.300

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.